- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04410458
Recruit Blood Donors Via SMS During Epidemic of COVID-19 (Repeat Trial)
May 29, 2020 updated by: Guangzhou Blood Center
Recruit Blood Donors Via SMS With Different Contents During Epidemic of COVID-19(Repeat Trial)
The fight against the spread of the 2019-nCoV epidemic has achieved some success in China, but the epidemic is far from over.
A key factor making the epidemic under control in China is the government's call for social distance, which has led to few people going out for donation.
As a result, the number of blood donors on the streets has been continuing to decline.
The first urgent recruitment of blood donors had been implemented during the period from 30 April to 10 May via emergency recruitment SMS .
This repeat trial has been designed to further confirm the results from the the first recruitment by comparing which information extraction frameworks would be more sensitive to blood donors in emergency situations.
Study Overview
Detailed Description
Researches has showed that that the information extraction and processing in emergency was different from the normal situation.
To understand what information the blood donors are more sensitive to in an environment that may pose a potential threat to themselves, the first urgent recruitment of blood donors had been implemented during the period from 30 April to 10 .
This interventional study is the repeat trail of the first trail.
The same with first trail, eligible blood donors in Guangzhou Blood Center has been randomly divided into four groups according to their sociological variables, their interval since last blood donation , their history donation times and the location of their last blood donation.
Three groups of donors has been randomly selected as interventional groups, and will receive three kindly of emergency blood donor recruitment SMS respectively.
The placebo group donors will only receive a thank-you SMS.
One recruitment SMS will emphasize what blood services will do to ensure the safety of blood donors during their donation in 2019-nCoV epidemic,one will shows information about a loss-based framework, while the third one will show information about a benefit-based framework .
Study Type
Interventional
Enrollment (Anticipated)
506517
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510095
- Guangzhou Blood Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Blood donors whose last turning up were between November 31, 2016 to November 31, 2019
Exclusion Criteria:
- Blood donors who were deferral by blood screening result and other situations. Blood donors who have indicated that they would not accept urgent recruitment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SMS with safty ensurance
SMS content in this group will be about what blood services will do to ensure the safety of blood donors' life saving donation during 2019-nCoV epidemic.
|
The literature shows that the information extraction and processing in emergency is different from the normal situation.
To find the most effective emergency recruitment method during an outbreak, we intervened with a well-balanced group of donors by presenting different emergency recruitment text messages.
|
Experimental: SMS with saving life call-1
SMS content in this group will be about calling the blood donors to a life saving donation.
|
The literature shows that the information extraction and processing in emergency is different from the normal situation.
To find the most effective emergency recruitment method during an outbreak, we intervened with a well-balanced group of donors by presenting different emergency recruitment text messages.
|
Experimental: SMS with saving life call-2
SMS content in this group will be about calling the blood donors to a life saving donation.
|
The literature shows that the information extraction and processing in emergency is different from the normal situation.
To find the most effective emergency recruitment method during an outbreak, we intervened with a well-balanced group of donors by presenting different emergency recruitment text messages.
|
Placebo Comparator: SMS with thank-you note
SMS content in this group will be thank-you note for their previous donation(s) .
|
The literature shows that the information extraction and processing in emergency is different from the normal situation.
To find the most effective emergency recruitment method during an outbreak, we intervened with a well-balanced group of donors by presenting different emergency recruitment text messages.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood donation rate
Time Frame: 12 days
|
Blood donation rate of donors in each group
|
12 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
May 31, 2020
Primary Completion (Anticipated)
May 31, 2020
Study Completion (Anticipated)
June 12, 2020
Study Registration Dates
First Submitted
May 29, 2020
First Submitted That Met QC Criteria
May 29, 2020
First Posted (Actual)
June 1, 2020
Study Record Updates
Last Update Posted (Actual)
June 1, 2020
Last Update Submitted That Met QC Criteria
May 29, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- Recruit Blood Donors via SMS 2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Donation
-
International Institute of Rescue Research and...Unknown
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI); University of Ghana; Syracuse... and other collaboratorsRecruiting
-
DGTI - Haemapheresis Vigilance Working PartyAix ScientificsActive, not recruitingBlood Donation With Hemapheresis
-
Uppsala University HospitalActive, not recruiting
-
The First Affiliated Hospital with Nanjing Medical...Nanjing Bioheng Biotech Co., Ltd.Unknown
-
Guangzhou Blood CenterCompleted
-
Haemonetics CorporationCompletedRed Blood Cell DonationUnited States
-
National University Hospital, SingaporeUnknownAnonymous Donors at Blood Donation Center (NUH)Singapore
-
HemanextCompletedWhole Blood Donation and LeukoreductionUnited States
-
Guangzhou Blood CenterUnknown
Clinical Trials on blood donation SMS
-
Guangzhou Blood CenterUnknown
-
Guangzhou Blood CenterCompleted
-
National Taiwan University HospitalUnknown
-
Zynex Monitoring SolutionsRecruitingBlood Loss | Fluid LossUnited States
-
Sykehuset Innlandet HFActive, not recruitingInflammation | Psychological Distress | Protein DeficiencyNorway
-
University College, LondonKing's College London; Imperial College London; Medical Research Council; Cancer...Active, not recruiting
-
Fraunhofer-Institute of Toxicology and Experimental...Hannover Medical SchoolCompletedAsthma | Allergic Rhinitis
-
Clinical Hospital Centre ZagrebCompletedHip Arthroplasty | Transfusion
-
Queen Mary University of LondonActive, not recruitingCardiovascular Diseases | Healthy | Inflammatory DiseaseUnited Kingdom
-
DGTI - Haemapheresis Vigilance Working PartyAix ScientificsActive, not recruitingBlood Donation With Hemapheresis